Patents Assigned to Robapharm AG
  • Method for producing ossein hydroxyapatite compound
    Patent number: 4919931
    Abstract: A method for producing an ossein hydroxyapatite compound from bones or fetal and young animals is described. The compound so produced stimulates chondrocytes and osteoblasts and is useful in the treatment of osteoarthritis, osteoporosis, bone and cartilage defects, and in the healing of bone fractures.
    Type: Grant
    Filed: February 5, 1987
    Date of Patent: April 24, 1990
    Assignee: Robapharm AG
    Inventor: Thea Rosenberg nee Goldner